Mansoura University
Al Mansurah, Egypt
NCT Number: NCT07426432
Aim of this study: evaluate the effect of fluoride-releasing composite resin as attachments on prevention of white spot lesions.
Material and methods:
Type: Prospective, randomized split mouth controlled study.
Interventions:
Intervention Group (Experimental Side):
•Application of fluoride-releasing composite
Control Group (Control Side):
•Application of conventional composite
Outcome Measures:
Primary Outcome: Incidence and Severity of White Spot Lesions
Secondary Outcomes:
1. Periodontal Ligament (PDL) Health 2. Gingival Bleeding and Inflammation
This study is active but is not currently recruiting participants.
Notify Me16 year–24 year
All sexes
Interventional
Not applicable
Al Mansurah, Egypt
Aim of the Study:
The aim of this study is to evaluate the effect of fluoride-releasing composite resin as attachments on prevention of white spot lesions (WSLs) development during clear aligner therapy in comparison to a split-mouth controlled group.
Material and methods:
Study Design:
Each participant will have one side of the mouth assigned to fluoride-releasing composite intervention as attachments, while the contralateral side will be assigned to conventional composite as attachments.
Sample size calculation:
Sample size calculation was based on effect of fluoride-releasing composite resin on prevention of White Spot Lesions during Clear Aligner Therapy: that was retrieved from most similar research Abdullah et al. Using G power program version 3.1.9.7 to calculate sample size based on effect size of 1.08 that is based on mean area of white spots, using 2-tailed test, α error = 0.05 and power = 95% , the total calculated sample size will be 24 in each group. To mitigate the potential impact of an anticipated 20% dropout rate, the recruitment target was increased to 30 patients per treatment group, aiming to ensure adequate statistical power in the final analyzed sample.
Inclusion criteria
Exclusion criteria
Interventions:
A 3D oral scan of the arch to be treated will be performed using a digital intraoral scanner
Aligners will be fabricated using thermoforming techniques. Intervention Group (Experimental Side): application of a fluoride-releasing composite on the indicated side of the mouth as attachments.
Control Group (Control Side): application of conventional composite as attachments.
Outcome Measures:
Primary Outcome: Incidence and Severity of White Spot Lesions Measured at base line, third (T1) and sixth (T2) months.
1.Laser fluorescence (DIAGNOdent), lesion defined as having a numerical score equal to or higher than (14).
Secondary Outcome:
Duration of the study:
•This study is suggested to be finished in 12 months.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
using fluoride releasing composite for attachment construction
using non fluoridated composite for attachment construction
Time frame: six months
Incidence and Severity of White Spot Lesions Measured at baseline, third (T1) and sixth (T2) months, by Laser fluorescence (DIAGNOdent), lesion defined as having a numerical score equal to or higher than (14).
Time frame: six months
Periodontal Ligament (PDL) Health using:
Time frame: six months
Gingival Bleeding Index (GBI) Dichotomous (yes/no bleeding) no=0 yes=1
Mansoura University
Other
Evaluate the Effect of Fluoride-Releasing Composite Resin on Prevention of White Spot Lesions During Clear Aligner Therapy: A Controlled Split-Mouth Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715552
White Spot Lesions
Irbid, Jordan
View Trial DetailsNCT06616207
Gingival Diseases, Gingival Inflammation and Bleeding
Seattle, Washington, United States
View Trial DetailsNCT06696105
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Jeddah, Saudi Arabia
View Trial DetailsNCT07707336
Enamel Demineralization, White Spot Lesions
Ajman, United Arab Emirates
View Trial Details